Search for: "Human Genome Sciences Inc. "
Results 21 - 40
of 125
Sort by Relevance
|
Sort by Date
3 Jan 2016, 7:03 pm
On April 21, CDC reported that whole genome sequencing confirmed that the people from Arizona (1) and Oklahoma (1) were part of the outbreak, bringing the total case count to 10. [read post]
3 Jan 2016, 5:33 am
On April 21, CDC reported that whole genome sequencing confirmed that the people from Arizona (1) and Oklahoma (1) were part of the outbreak, bringing the total case count to 10. [read post]
19 Nov 2015, 6:38 pm
FDA said it had based the decision “on sound science and a comprehensive review” and had concluded that consumption of the GE salmon poses no threat to human safety or the environment. [read post]
9 Nov 2015, 7:39 am
Common general knowledge ('CGK')While many CGK propositions were agreed between the parties, there was still much uncertainty surrounding this area of science at the priority date. [read post]
13 Oct 2015, 10:01 pm
“If the science shows there’s not a problem, the agency will be flexible,” he said. [read post]
11 Jul 2015, 3:08 am
In the same month, a team led by Feng Zhang at the Broad Institute, Inc and MIT reported similar success using CRISPR to edit human genes.Which brings me to the main topic of this post. [read post]
27 May 2015, 7:00 am
Co. v. 23andMe, Inc., 2015 U.S. [read post]
26 May 2015, 7:42 am
Essentially, the allegations seek to impose a non-FDA-approved contraindication, using state law, based upon human genetic variability. [read post]
25 May 2015, 1:28 am
In Human Genome Sciences Inc. v Eli Lilly and Company [2011] UKSC 51 the Supreme Court reversed the findings of the High Court and Court of Appeal. [read post]
26 Apr 2015, 6:14 pm
As an example if one considers how inventive step was assessed in Teva UK Limited & Teva Pharmaceuticals Limited v Leo Pharma A/S & Leo Laboratories Limited [2014] EWHC 3096 (Pat) (see Katpost here) one sees that for a pharmaceutical formulation the following criteria may be relevant:* obvious to try * reasonable expectation of success * prejudice * inventive selection * the Technograph test (Technograph v Mills & Rockley [1972] RPC 346) * synergyMr Justice Birss… [read post]
11 Dec 2014, 2:16 pm
The property, at 9911 Belward Campus Drive, is 289,900 square feet and 100 percent leased to Human Genome Sciences Inc. [read post]
8 Nov 2014, 11:00 pm
So, what is the science? [read post]
8 Nov 2014, 10:23 am
So, what is the science? [read post]
21 Jul 2014, 10:32 am
”Even here, however, we see signs that UK courts are trying to be more consistent with the EPO, and in the HGS v Lilly litigation, reading the decision of the Supreme Court in Human Genome Sciences Inc. v Eli Lilly and Company [2011] UKSC 51 (see IPKat here) it is possible discern in the judgment a desire to not only apply the jurisprudence of the EPO Boards of Appeal, but also to reach the same conclusion (of sufficiency of the claims) on the specific… [read post]
7 Mar 2014, 3:00 am
The move comes with the formation of Human Longevity, Inc. [read post]
9 Feb 2014, 6:18 am
Stanford and Stanford faculty-founded companies such as Stem Cells Inc, are blatantly promoted over others. [read post]
12 Dec 2013, 7:12 am
In short, where the patent holder has already obtained an SPC on the basis of a patent protecting an innovative active ingredient and a marketing authorisation for a medicinal product containing that ingredient as the single active ingredient, and that SPC entitles him to oppose the use of that active ingredient, either alone or in combination with other active ingredients, Article 3(c) of the SPC Regulation must be interpreted as precluding that patent holder from obtaining –- on the basis of… [read post]
21 Jun 2013, 10:22 am
[If you want some handy tips on how to speed-read all those comments, try the Wired How-To Wiki, here] In case you missed it, Eli Lilly and Company v Human Genome Sciences, Inc UKSC 2012/0220 is not going on appeal to the United Kingdom's Supreme Court. [read post]
19 Jun 2013, 6:12 am
” In a case that has profound implications for the life sciences industry, the Court ruled last week that complementary DNA (cDNA), derived of human intervention, is patent eligible subject matter; but that unaltered DNA, merely by its isolation from the human genome, is not patent eligible. [read post]
21 May 2013, 2:59 pm
Internationally renown scientist Lee Hood, winner of a National Medal of Science, violated the conflict of interest policies of the California stem cell agency earlier this year when he was involved in reviewing applications in a $40 million round to create genomics centers in California. [read post]
